soul trial oral semaglutide cardiovascular outcomes results 2025 nejm 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM In patients with type 2

Its two RLT products Lutathera (lutetium-177 DOTATATE) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and Pluvicto (lutetium-177 PSMA-617) for metastatic castration-resistant prostate cancer represent the most commercially advanced radioligand therapy platform in the world and occupy the Oncology Peptide Therapy segment, which the report forecasts to grow at 11.79% CAGR through 2031

Activated platelets release mediatorsserotonin, thromboxane A, adenine nucleotides, stromal-derived factor-1, and transforming growth factor-that mitigate cardiomyocyte death during ischemia [148,149,150]

Mounjaro interactions Mounjaro can interact with other drugs, so it's important to discuss all other medications you're taking with your provider

Editor BuhlmanL

Signs of Skin Inflammation and Acne-Related Marks Skin inflammation often manifests as visible and textural changes on the face and body, especially when acne triggers prolonged immune responses in the skin

A proposed clinical staging system for obesity